AIM
FOMX

Acrospire Investment Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Acrospire Investment Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-811
Closed -$9K – 2625
2016
Q4 		$9K Buy
+811
New +$7.63K ﹤0.01% 1978

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Acrospire Investment Management's FOMX Position: Q1 2017 in Review

Acrospire Investment Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2017, closing a stake of 811 shares — an estimated $9K sold.

Acrospire Investment Management first reported a position in FOMX in Q4 2016 and held it in 1 quarter. The position peaked at $9K in Q4 2016. 67 funds tracked by Wall St. Rank hold FOMX as of Q1 2017.

  • Acrospire Investment Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 811 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2017, an estimated $9K.
  • Acrospire Investment Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2016 and held it in 1 quarter.
  • Acrospire Investment Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $9K in Q4 2016.
  • 67 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.